Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
36.83
-1.17 (-3.08%)
Jun 13, 2025, 3:00 PM CST
SHA:600211 Market Cap
SHA:600211 has a market cap or net worth of 12.25 billion as of June 13, 2025. Its market cap has increased by 0.77% in one year.
Market Cap
12.25B
Enterprise Value
9.67B
Revenue
2.81B
Ranking
n/a
PE Ratio
12.14
Stock Price
36.83
Market Cap Chart
Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 12.25B, an increase of 745.84%. That is a compound annual growth rate of 8.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 362.57B |
Shenzhen Mindray Bio-Medical Electronics | 287.01B |
WuXi AppTec | 187.32B |
Sichuan Biokin Pharmaceutical | 131.53B |
Zhangzhou Pientzehuang Pharmaceutical., | 121.75B |
Aier Eye Hospital Group | 115.36B |
Shanghai United Imaging Healthcare | 108.39B |
Yunnan Baiyao Group Co.,Ltd | 101.69B |